Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT in advanced pancreatic cancer
NCT02118077Phase 3Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Apr 2001
- Primary completion
- Apr 2004
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of G17DT immunogen in pancreatic carcinoma, sponsored by Cancer Advances, Inc.. Started Apr 2001; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT02118077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118077.